Possible role of new pressor protein in hypertensive anephric hemodialysis patients

Pediatric Nephrology

Volumn 18, Issue 10, 2003, Pages 1025-1031

  Pearl, Rachel J ^a   Papageorgiou, Peter C ^b,c   Goldman, Michael ^a   Amfilochiadis, Akis A ^b,c   Boomsma, Frans ^d   Rojkjaer, Rasmus ^e   Geary, Denis ^a   Osmond, Daniel H ^b,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e NOVO NORDISK A S   (Denmark)

Author keywords

Extra renal enzyme; Factor XIIa; Hemodialysis; Hypertension; New pressor protein; Pressor activity

Indexed keywords

AMLODIPINE; BLOOD CLOTTING FACTOR 12A; CAPTOPRIL; HYPERTENSIVE FACTOR; NADOLOL; NEW PRESSOR PROTEIN; RENIN; SOYBEAN TRYPSIN INHIBITOR; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; BIOLOGICAL MODEL; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CASE REPORT; DRY WEIGHT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; HYPERVOLEMIA; IMMUNOASSAY; KIDNEY AGENESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ANIMALS; BIOLOGICAL ASSAY; BLOOD PRESSURE; BLOOD PROTEINS; CHILD; FACTOR XIIA; HUMANS; HYPERTENSION, RENAL; MALE; NEPHRECTOMY; RATS; RENAL DIALYSIS; TRYPSIN;

EID: 0141989627     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1246-6     Document Type: Article

References (22)

1. Mendley SR, Fine R, Tejani A (2001) Dialysis in infants and children. In: Daugirdas JT, Blake PG, Ing TS (eds) Handbook of dialysis, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 562-579
2. Horl MP, Horl WH (2002) Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis 39: 227-244
3. Converse RLJ, Jacobsen TN, Toto RD, Jost CM, Consentino F, Fouad-Tarazi F, Victor RG (1992) Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327: 1912-1918
4. Komatsu Y, Ito K (1992) Erythropoietin associated hypertension among pediatric dialysis patients. Adv Perit Dial 8:448-452
5. Seguias L, Zilleruelo G, Strauss J, Abitbol C, Montane B (2001) Angiotensin-II and endothelin-1 levels in children with renoprival hypertension. Pediatr Nephrol 16:493-496
6. Osmond DH, Mavrogiannis L, Cotter BR (1998) Potent 'new pressor protein' related to coagulation factor XII is potentiated by inhibition of angiotensin converting enzyme inhibition (ACEI). J Hypertens 16:311-320
7. Mavrogiannis L, Kariyawasam KPAP, Osmond DH (1997) Potent blood pressure raising effects of activated coagulation factor XII. Can J Physiol Pharmacol 75:1398-1403
8. Mavrogiannis L, Trambakoulos D, Boomsma F, Osmond DH (2002) The sympathoadrenal system mediates the blood pressure and cardiac effects of human coagulation FXII-related "new pressor protein". Can J Cardiol 18:1077-1086
9. Simos D, Boomsma F, Osmond DH (2002) Human coagulation FXII-related 'new pressor protein': role of PACAP in its cardiovascular and sympathoadrenal effects. Can J Cardiol 18:1093-1103
10. Coppola R, Cristilli P, Cugno M, Ariens RA, Mari D, Mannucci PM (1996) Measurement of activated factor XII in health and disease. Blood Coagul Fibrinolysis 7:530-535
11. Salmon J, Cardigan R, Mackie I, Cohen SL, Machin S, Singer M (1997) Continuous venovenous hemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways. Intensive Care Med 23:38-43
12. Matsuo T, Koide M, Kario K, Suzuki S, Matsuo M (1997) Extrinsic coagulation factors and tissue factor pathway inhibitor in end-stage chronic renal failure. Haemostasis 27:163-167
13. Svensson M, Friberger P, Lundstrom O, Stegmayr B (1996) Activation of FXII during haemodialysis. Scand J Clin Lab Invest 56:649-652
14. Frank RD, Weber J, Dresbach H, Thelen H, Weiss C, Floege J (2001) Role of contact system activation in hemodialyzer-induced thrombogenicity. Kidney Int 60:1972-1981
15. Colhoun HM, Zito F, Norman Chan N, Rubens MB, Fuller JH, Humphries SE (2002) Activated factor XII levels and factor XII 46C>T genotype in relation to coronary artery calcification in patients with type 1 diabetes and healthy subjects. Atherosclerosis 163:363-369
16. Nevard CHF, Jurd KM, Lane D, Philippou H, Haycock GB, Hunt BJ (1997). Activation of coagulation and fibrinolysis in childhood diarrhoea-associated haemolytic uraemic syndrome. Thromb Haemost 78:1450-1455
17. Hoorn FA van der, Boomsma F, Man in 't Veld AJ, Schalekamp MA (1989). Determination of catecholamines in human plasma by high-performance liquid chromatography: comparison between a new method with fluorescence detection and an established method with electrochemical detection. J Chromatogr 487:17-28
18. Renaux JL, Thomas M, Crost T, Loughraieb N, Vantard G (1999) Activation of the kallikrein-kinin system in hemodialysis: role of membrane electronegativity, blood dilution and pH. Kidney Int 55:1097-1103
19. Rich JB (1998) The efficacy and safety of aprotinin use in cardiac surgery. Ann Thor Surg 66 [Suppl 5]:S6-S11
20. Asimakopoulos G (2001) Systemic inflammation and cardiac surgery: an update. Perfusion 16:353-360
21. Jaquiss RD, Ghanayem NS, Zacharisen MC, Mussatto KA, Tweddell JS, Litwin SB (2002) Safety of aprotinin use and re-use in pediatric cardiothoracic surgery. Circulation 106 [Suppl 1]:I90-194
22. Tweddell JS, Hoffman GM, Mussatto KA, Fedderly RT, Berger S, Jaquiss RD, Ghanayem NS, Frisbee SJ, Litwin SB (2002) Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients. Circulation 106 [Suppl 1]:182-189